Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BIIB
Recent news which mentions BIIB
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
31
32
Next >
Why This Analyst Believes Biogen Is 'Too Good to Ignore'
April 18, 2022
Tickers
BIIB
Tags
Benzinga
Wells Fargo
Analyst Color
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2022
April 18, 2022
Tickers
AJG
APTV
AXTA
BCRX
Tags
EVER
WEN
MAC
From
Benzinga
3 Biotech Stocks That Could Help Make You a Fortune
April 14, 2022
Tickers
AMGN
BIIB
MRNA
NVAX
Tags
MRNA
Recent Press Releases
BIIB
From
Motley Fool
Biogen’s Aduhelm Crashes the Biotech Sector
April 13, 2022
Tickers
BIIB
NVS
VTRS
Tags
BIIB
Stocks to Sell
VTRS
From
InvestorPlace
Recession Fears are Creating a Golden Opportunity for Biotech Stocks
April 08, 2022
Tickers
AZN
BIIB
ENTX
GLSI
Tags
ENTX
AZN
LGVN
From
InvestorPlace
Why Is Trevi Therapeutics (TRVI) Stock On the Move Today?
April 08, 2022
Tickers
BIIB
CRWD
EDU
TRVI
Tags
NASDAQ:TRVI,NASDAQ:CRWD,NYSE:EDU,NASDAQ:BIIB
CRWD
TRVI
From
InvestorPlace
Why Is Biogen (BIIB) Stock in the Spotlight Today?
April 08, 2022
Tickers
BIIB
LLY
Tags
Market News
Today's Market
NASDAQ:BIIB,NYSE:LLY
From
InvestorPlace
Morning Brief: Top Stories Dominating Financial Media on Friday, April 8
April 08, 2022
Tickers
AMZN
BA
BIIB
BRK-A
Tags
TOSYY
BRK/A
JPM
From
Benzinga
Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks
April 08, 2022
Tickers
BIIB
BLUE
GILD
IBB
Tags
XBI
BLUE
Penny Stocks
From
InvestorPlace
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
April 08, 2022
Tickers
BIIB
Tags
News
Government
General
From
Benzinga
3 Healthcare Stocks That Could Help Set You Up for Life
April 07, 2022
Tickers
BIIB
GMED
LLY
SGEN
Tags
SGEN
Market News
GMED
From
Motley Fool
Could Amylyx Pharmaceuticals Have a Blockbuster ALS Treatment?
March 29, 2022
Tickers
AMLX
BIIB
Tags
Recent Press Releases
BIIB
Market News
From
Motley Fool
Ionis-Biogen Partnered Amyotrophic Lateral Sclerosis Trial Disappoints
March 28, 2022
Tickers
BIIB
IONS
Tags
BIIB
Health Care
Phase 1 Trial
From
Benzinga
Is Johnson & Johnson Setting a Dangerous Precedent for the Healthcare Industry?
March 26, 2022
Tickers
BIIB
JNJ
MRNA
OCGN
Tags
OCGN
Market News
JNJ
From
Motley Fool
Why I Sold Kohl’s Corporation Despite Possible Buyout Deal
March 22, 2022
Tickers
BIIB
KSS
NLSN
Tags
NYSE:KSS,NYSE:NLSN,NASDAQ:BIIB
Market News
BIIB
From
InvestorPlace
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
March 22, 2022
Tickers
BIIB
ESALF
ESALY
Tags
ESALF
ESALY
Briefs
From
Benzinga
2 Red Flags for Biogen's Future
March 22, 2022
Tickers
BIIB
LLY
Tags
Recent Press Releases
BIIB
LLY
From
Motley Fool
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
March 16, 2022
Tickers
BIIB
Tags
BIIB
Phase 3 Trial
General
From
Benzinga
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
March 15, 2022
Tickers
BIIB
ESALF
ESALY
Tags
ESALF
General
ESALY
From
Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
March 15, 2022
Tickers
ALT
ANAB
ANIP
ATHX
Tags
ANIP
Offerings
Biotech
From
Benzinga
Biogen Posts New Updates Across its Spinraza SMA Research Program
March 14, 2022
Tickers
BIIB
NVS
RHHBY
Tags
Benzinga
Market News
RHHBY
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022
March 08, 2022
Tickers
ACET
ACTD
ALEC
AREN
Tags
FULC
ENVB
AREN
From
Benzinga
10 Biggest Price Target Changes For Tuesday
March 08, 2022
Tickers
AUPH
AVDX
BBBY
BIIB
Tags
AVDX
AUPH
CARA
From
Benzinga
As President Biden proposed, Medicare needs the ability to negotiate drug prices
March 07, 2022
Tickers
BIIB
Tags
BIIB
From
MarketWatch
The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan
March 04, 2022
Tickers
BIIB
CEMI
ESALY
EYEN
Tags
OCGN
IBB
CEMI
From
Benzinga
Why This Analyst Sees Roughly 20% Upside In This Large-Cap Biopharma
March 03, 2022
Tickers
BIIB
Tags
Brian Abrahams
Analyst Color
General
From
Benzinga
Expert Ratings For Biogen
March 03, 2022
Tickers
BIIB
Tags
BZI/AAR
BIIB
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022
March 03, 2022
Tickers
ALGT
AORT
AVTX
BALY
Tags
NBIX
BRT
Upgrades
From
Benzinga
10 Biggest Price Target Changes For Thursday
March 03, 2022
Tickers
AEO
AI
BHG
BIIB
Tags
Industrials
BHG
Pre/Market Outlook
From
Benzinga
Viatris stock slides 24% as analysts say sale of biosimilars to Indian partner removes key growth driver
February 28, 2022
Tickers
BIIB
PFE
VTRS
Tags
BIIB
PFE
VTRS
From
MarketWatch
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.